GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Institutional Ownership

Itonis (Itonis) Institutional Ownership : 0.00% (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Itonis's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Itonis's Insider Ownership is 9.38%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Itonis's Float Percentage Of Total Shares Outstanding is 0.00%.


Itonis Institutional Ownership Historical Data

The historical data trend for Itonis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Institutional Ownership Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Institutional Ownership
- - -

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Institutional Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Itonis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines